Announcements

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

• Adriana Burlea-Schiopoiu;
• Alban Kuriqi;
• Álvaro González-Vila;
• Alessandro Alaimo;
• Alexey Beskopylny;
• Alexander Yu Churyumov;
• Alberto Fernández-Isabel;
• Andrea Mastinu;
• Antonios N. Papadopoulos;
• Anton Rassõlkin;
• Antonio Humberto Hamad Minervino;
• Arkadiusz Matwijczuk;
• Artur Słomka;
• Baojie He;
• Bartłomiej Potaniec;
• Bojan Đurin;
• Camilo Arturo Rodriguez Diaz;
• Carmelo Maria Musarella;
• Chiachung Chen;
• Chiman Kwan;
• Cristian Busu;
• Danil Pimenov;
• Dan-Cristian Dabija;
• Delfín Ortega-Sánchez;
• Demetrio Antonio Zema;
• Denis Butusov;
• Elena Lucchi;
• Gaurab Dutta;
• Livia Anastasiu;
• M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

MDPI will be attending the 2021 Chinese Medicinal Chemistry Symposium and CPA-EFMC International Symposium on Medicinal Chemistry (CMCS 2021), hosted by the Division of Medicinal Chemistry and Chinese Pharmaceutical Association, which will be held from Monday, 27 September, until Thursday, 30 September 2021, in Shenyang, China.

As a top-level biennial event in the medicinal chemistry and the related fields in China, CMCS aims to boost the information exchange and communication between peers in frontiers of medicinal chemistry and the relevant fields. According to the cooperation framework agreement signed by the Chinese Pharmaceutical Association (CPA) and the European Federation for Medicinal Chemistry (EFMC), the CPA-EFMC International Symposium on Medicinal Chemistry (CPA-EFMC ISMC) will be held concurrently.

The topics covered will include the frontiers and hotspots of medicinal chemistry and chemical biology, innovative drug research for major diseases, rational drug design strategies and new methods, lead compound discovery and optimization strategies, natural active substance discovery and structural modification, and modern drug preparation technology and innovation craft.

The following MDPI journals will be represented:

• Molecules;
• Antibiotics;
• Medical Sciences.

If you are also attending this conference, please feel free to stop by our booth (#16). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://cmcs2021.syphu.edu.cn/Home.htm.

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available on PubMed; full texts are archived in PubMed Central. Antibiotics has a Journal Impact Factor of 4.639, ranking 26/92 (Q2) in the "Infectious Diseases" category, and 75/275 (Q2) in the "Pharmacology & Pharmacy" category in the Web of Science. We wouldn’t have made such progress without your valuable suggestions and support.

The main responsibilities of the Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conference/society cooperation recommendations.

This position is open to experts on all aspects of antibiotics. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Sections of Antibiotics

1. Antibiotics Use and Antimicrobial Stewardship
2. Novel Antimicrobial Agents
3. Antimicrobial Peptides
4. Biosynthesis and Combinatorial Approaches in Antimicrobial Discovery
5. Mechanism and Evolution of Antibiotic Resistance
6. Fungi and their Metabolites
7. Pharmacokinetics and Pharmacodynamics of Drugs
8. Plant-Derived Antibiotics
9. Mechanisms of Antibiotic Action
10. Structures of Bacterial Proteins
11. Biochemical and Genetics Studies of Infectious Disease Progression and Intervention
12. Bacteriophages
13. The Global Need for Effective Antibiotics
14. Antibiotic Therapy in Infectious Diseases
15. Antimicrobial Materials and Surface
16. Antibiofilm Strategies
17. Antibiotics in Animal Health

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Antibiotics:

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

• 10 journals received their first impact factor
• 96% of journals increased their impact factor from 2019
• 32 journals (38%) ranked among the top 25% of journals, in at least one category

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/92 (Q2) in 'Infectious Diseases' and 75/275 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendation.

This position is open to experts on all aspects of the mechanism and evolution of antibiotic resistance. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/92 (Q2) in 'Infectious Diseases' and 75/275 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendations.

Antibiotics (ISSN 2079-6382, https://www.mdpi.com/journal/antibiotics) is an international, peer-reviewed, open access journal published online by MDPI, Basel, Switzerland. The scope of Antibiotics includes, but is not limited to: pharmacodynamics, uses of antibiotics, antimicrobial stewardship, antibiotic resistance, and novel antimicrobial agents. We aim to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The journal has been indexed by the Science Citation Index Expanded (SCIE: Web of Science), Scopus, and other databases. Citations are available in PubMed, full text is archived in PubMed Central. Its Impact Factor is 4.639 (2020), ranking 26/93 (Q2) in 'Infectious Diseases' and 75/270 (Q2) in 'Pharmacology & Pharmacy’ in JCR.

The main responsibilities of the Section Editorial Board Members are as follows:

1. Supervising the quality of the papers in this section (when we have new submissions to the section);
2. Acting or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
3. Providing any conferences/society cooperation recommendations.

This position is open to experts on all aspects of antibiotic use and antimicrobial stewardship. To apply for this position, recommend potential candidates, or request further information, please contact the Antibiotics Editorial Office (antibiotics@mdpi.com) or Managing Editor, Ms. Chole Lu (chloe.lu@mdpi.com).